Research ArticleVasculitis
Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis
Shubhasree Banerjee, Kaitlin A. Quinn, K. Bates Gribbons, Joel S. Rosenblum, Ali Cahid Civelek, Elaine Novakovich, Peter A. Merkel, Mark A. Ahlman and Peter C. Grayson
The Journal of Rheumatology January 2020, 47 (1) 99-107; DOI: https://doi.org/10.3899/jrheum.181222
Shubhasree Banerjee
From the Systemic Autoimmunity Branch, US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, Maryland; Division of Rheumatology, Georgetown University, Washington, DC; National Institutes of Health, Clinical Center, Radiology and Imaging Sciences, Bethesda, Maryland; Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania,
USA.
Kaitlin A. Quinn
K. Bates Gribbons
Joel S. Rosenblum
Ali Cahid Civelek
Elaine Novakovich
Peter A. Merkel
Mark A. Ahlman
Peter C. Grayson
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 47, Issue 1
1 Jan 2020
Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis
Shubhasree Banerjee, Kaitlin A. Quinn, K. Bates Gribbons, Joel S. Rosenblum, Ali Cahid Civelek, Elaine Novakovich, Peter A. Merkel, Mark A. Ahlman, Peter C. Grayson
The Journal of Rheumatology Jan 2020, 47 (1) 99-107; DOI: 10.3899/jrheum.181222
Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis
Shubhasree Banerjee, Kaitlin A. Quinn, K. Bates Gribbons, Joel S. Rosenblum, Ali Cahid Civelek, Elaine Novakovich, Peter A. Merkel, Mark A. Ahlman, Peter C. Grayson
The Journal of Rheumatology Jan 2020, 47 (1) 99-107; DOI: 10.3899/jrheum.181222